Other
David Chi, MD
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
Failure Rate
75.0%
3 terminated/withdrawn out of 4 trials
Success Rate
0.0%
-86.5% vs industry average
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
3 of 0 completed trials have results
Key Signals
3 with results
Enrollment Performance
Analytics
Phase 1
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 1(2)
N/A(1)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT06191562Not ApplicableActive Not Recruiting
Posterior vs. Anterior Tympanostomy Tube Placement
Role: lead
NCT04879823Phase 3Terminated
Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity
Role: lead
NCT04791761Phase 1Terminated
Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
Role: lead
NCT03618823Phase 1Terminated
Non-opioids for Analgesia After Adenotonsillectomy in Children
Role: lead
All 4 trials loaded